RE:RE:RE:RE:RE:RE:RE:RE:PJLet me educate you a little here. Cinven acquired Amdipharm and Mercury in 2012 and merged them into AmCo. They built it on a period of 3 years until the sell to CXR in 2015. That, my dear, is patience at work.
Now you're here telling me that, god forbid, they have no choice but to liquidate their holdings under this short-term pressure ? What planet are you from ?
This board...
terminator007 wrote: Cinven has no choice but to accept the 58 cad offer or remain underwater for few more years.
There is no gurantee that they would get to that 85 cad price tag even in three years.
I think they would take this offer given the political situation and/or sector performance.
CNInvesting wrote: Wrong. It's NOT worth what the market deems it and that's the whole drama around this stock. Ever heard about fair value ? Intrinsic value maybe ? The markets are biased and distorted as we know and so do you. Tell me Craig, a stock that's shorted on 25% of its float is ''worth what the market deems it'' ? Wrong. The stock is manipulated so as to NOT reflect its value.
Cinven already got their money back ? The shares were gravy ? What the hell are you talking about. Their ''gravy'' was $700 million USD worth of stock of CXR! The other part was $1.2 billion USD in cash and the rest is debt. We're talking about roughly 50% of the cash/equity portion in stock and you call it gravy ??The hell, get lost.
No way this passes at this price. No way. Period.
Craigbad wrote: It's worth what the market deems its worth and today that was $34 period. Sure some people will be underwater at a $50 buyout but they can make returns with the money elsewhere, simple as that. If there is no brexit and its $58 all the better, alot of people bought at $30 and thats near a double. Cinven already got all of their investment out and more in cash when they sold, the shares they received are just gravy. I'm feeling alot more confident with Ambers update today as it seemed legit and she seemed confident in her source.